Log In
BCIQ
Print this Print this
 

BGB-A317

  Manage Alerts
Collapse Summary General Information
Company BeiGene Ltd.
DescriptionHumanized IgG4 mAb against PD-1
Molecular Target Programmed cell death 1 (PD-1) (PDCD1) (CD279)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today